No CrossRef data available.
Article contents
Neuroleptic malignant syndrome
Published online by Cambridge University Press: 02 January 2018
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static-cambridge-org.ezproxyberklee.flo.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0007125000140875/resource/name/firstPage-S0007125000140875a.jpg)
- Type
- Correspondence
- Information
- Copyright
- Copyright © Royal College of Psychiatrists, 1990
References
Addonizio, G., Susman, V. L. & Roth, S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry, 143, 1587–1590.Google Scholar
Peet, M. & Collier, J. (1990) Use of carbamazepine in psychosis after neuroleptic malignant syndrome. British Journal of Psychiatry, 156, 579–581.CrossRefGoogle ScholarPubMed
Velamoor, V. R., Fernando, M. L. D. & Williamson, P. (1990) Incipient neuroleptic malignant syndrome. British Journal of Psychiatry. 156, 581–584.Google Scholar
West, A. P. & Meltzer, H. Y. (1979) Paradoxical lithium neurotoxicity: a report of five cases and a hypothesis about risk for neurotoxicity. American Journal of Psychiatry, 136, 963–966.Google Scholar
eLetters
No eLetters have been published for this article.